The epidemiology of atrial fibrillation in end-stage renal disease

Journal of Nephrology

Volumn 26, Issue 4, 2013, Pages 617-623

  Korantzopoulos, Panagiotis ^a   Liu, Tong ^b   Letsas, Konstantinos P ^c   Fragakis, Nikolaos ^d   Kyrlas, Konstantinos ^a   Goudevenos, John A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^c EVANGELISMOS HOSPITAL   (Greece)

^d ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

Atrial fibrillation; End stage renal disease; Epidemiology; Incidence; Predictors; Prevalence; Renal failure

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ASYMPTOMATIC DISEASE; CARDIOVASCULAR MALFORMATION; CARDIOVASCULAR RISK; DEFIBRILLATION; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; INCIDENCE; KIDNEY FAILURE; MORTALITY; PATIENT MONITORING; PERITONEAL DIALYSIS; PREDICTION; PREVALENCE; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYMPTOM; TREATMENT DURATION;

ATRIAL FIBRILLATION; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; PREVALENCE; RISK FACTORS;

EID: 84880108339     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000270     Document Type: Review

References (37)

1. Remppis A, Ritz E. Cardiac problems in the dialysis patient: beyond coronary disease. Semin Dial. 2008;21(4):319-325.
2. Kanbay M, Afsar B, Goldsmith D, Covic A. Sudden death in hemodialysis: an update. Blood Purif. 2010;30(2):135-145.
3. Hsu CY, Vittinghoff E, Lin F, Shlipak MG. The incidence of endstage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med. 2004;141(2):95-101.
4. Kocheril AG. Arrhythmia issues in patients with renal disease. Semin Nephrol. 2001;21(1):57-65.
5. Korantzopoulos P, Liu T, Li L, Goudevenos JA, Li G. Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis. Europace. 2009;11(11):1469-1475.
6. Vardas PE, Mavrakis HE. Atrial fibrillation: a symptom treated as a disease? Hellenic J Cardiol. 2006;47(4):191-193.
7. Kannel WB, Benjamin EJ. Current perceptions of the epidemiology of atrial fibrillation. Cardiol Clin. 2009;27(1):13-24, vii.
8. Alonso A, Lopez FL, Matsushita K, et al. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123(25):2946-2953.
9. Korantzopoulos P, Kokkoris S, Liu T, Protopsaltis I, Li G, Goudevenos JA. Atrial fibrillation in end-stage renal disease. Pacing Clin Electrophysiol. 2007;30(11):1391-1397.
10. Korantzopoulos PG, Goudevenos JA. Atrial fibrillation in end-stage renal disease: an emerging problem. Kidney Int. 2009;76(3):247-249.
11. Atta MG. Atrial fibrillation in dialysis patients: a neglected comorbidity. J Am Soc Nephrol. 2011;22(2):203-205.
12. Camm AJ, Kirchhof P, Lip GY, et al; European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369-2429.
13. Camm AJ, Lip GY, De Caterina R, et al; ESC Committee for Practice Guidelines (CPG); Document Reviewers. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719-2747.
14. Abe S, Yoshizawa M, Nakanishi N, et al. Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J. 1996;131(6):1137-1144.
15. Vázquez E, Sánchez-Perales C, Borrego F, et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J. 2000;140(6):886-890.
16. Fabbian F, Catalano C, Lambertini D, et al. Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. Clin Nephrol. 2000;54(3):234-239.
17. Ansari N, Manis T, Feinfeld DA. Symptomatic atrial arrhythmias in hemodialysis patients. Ren Fail. 2001;23(1):71-76.
18. Abbott KC, Trespalacios FC, Taylor AJ, Agodoa LY. Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrol. 2003;4(1):1.
19. Genovesi S, Pogliani D, Faini A, et al. Prevalence of atrial fibrillation and associated factors in a population f long-term hemodialysis patients. Am J Kidney Dis. 2005;46(5):897-902.
20. Atar I, Konaş D, Açikel S, et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol. 2006;106(1):47-51.
21. Vázquez-Ruiz de, Castroviejoa E, Sánchez-Perales C, LozanoCabezas C, et al. Incidence of atrial fibrillation in hemodialysis patients: a prospective long-term follow-up study [article in Spanish]. Rev Esp Cardiol. 2006;59(8):779-784.
22. Genovesi S, Vincenti A, Rossi E, et al. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis. 2008;51(2):255-262.
23. Vazquez E, Sanchez-Perales C, Garcia-Garcia F, et al. Atrial fibrillation in incident dialysis patients. Kidney Int. 2009;76(3):324-330.
24. Wizemann V, Tong L, Satayathum S, et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int. 2010;77(12):1098-1106.
25. Acar G, Akçay A, Dog̀an E, et al. The prevalence and predictors of atrial fibrillation in hemodialysis patients. Turk Kardiyol Dern Ars. 2010;38(1):8-13.
26. Fujii H, Kim JI, Yoshiya K, Nishi S, Fukagawa M. Clinical characteristics and cardiovascular outcomes of hemodialysis patients with atrial fibrillation: a prospective follow-up study. Am J Nephrol. 2011;34(2):126-134.
27. Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol. 2011;22(2):349-357.
28. Tsagalis G, Bakirtzi N, Manios E, et al. Atrial fibrillation in chronic hemodialysis patients: prevalence, types, predictors, and treatment practices in Greece. Artif Organs. 2011;35(10):916-922.
29. Wetmore JB, Mahnken JD, Rigler SK, et al. The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaideligible dialysis patients. Kidney Int. 2012;81(5):469-476.
30. Goldstein BA, Arce CM, Hlatky MA, Turakhia M, Setoguchi S, Winkelmayer WC. Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States. Circulation. 2012;126(19):2293-2301.
31. Szczech LA. Atrial fibrillation: the beat is faster than the answers. Kidney Int. 2012;81(5):432-433.
32. Piccini JP, Sinner MF, Greiner MA, et al. Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation. 2012;126(18):2200-2207.
33. Chou CY, Kuo HL, Wang SM, et al. Outcome of atrial fibrillation among patients with end-stage renal disease. Nephrol Dial Transplant. 2010;25(4):1225-1230.
34. Lim HS, Lip GY. Asymptomatic atrial fibrillation on device interrogation. J Cardiovasc Electrophysiol. 2008;19(8):891-893.
35. Grande A. Atrial fibrillation and dialysis. A convergence of risk factors [article in Spanish]. Rev Esp Cardiol. 2006;59(8):766-769.
36. Schlaich MP, Schmieder RE. Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents. Am J Hypertens. 1998;11(11 Pt 1):1394-1404.
37. Bossola M, Tazza L, Vulpio C, Luciani G. Is regression of left ventricular hypertrophy in maintenance hemodialysis patients possible? Semin Dial. 2008;21(5):422-430.